Crossover study with cisplatin or carboplatin in advanced ovarian cancer
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 39 (2) , 146-149
- https://doi.org/10.1016/0090-8258(90)90422-h
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Cisplatin/carboplatin cross-resistance in ovarian cancerBritish Journal of Cancer, 1989
- Resistance to platinum compounds: Mechanisms and beyondEuropean Journal of Cancer and Clinical Oncology, 1989
- Carboplatin: current status and future prospectsCancer Treatment Reviews, 1988
- Phase II study of iproplatin in advanced ovarian carcinoma.Journal of Clinical Oncology, 1988
- High-dose carboplatin in refractory ovarian cancer patients.Journal of Clinical Oncology, 1987
- Charles F. Kettring prize. Fundamental studies with cisplatinCancer, 1985
- INDUCTION AND REPAIR OF DNA CROSS-LINKS IN CHINESE-HAMSTER OVARY CELLS TREATED WITH VARIOUS PLATINUM COORDINATION-COMPOUNDS IN RELATION TO PLATINUM BINDING TO DNA, CYTO-TOXICITY, MUTAGENICITY, AND ANTITUMOR-ACTIVITY1984
- Cis-platinum: a new anticancer agent.BMJ, 1979